nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—psoriasis—skin cancer	0.537	1	CtDrD
Hydrocortisone—ABCG2—Vismodegib—skin cancer	0.0583	0.169	CbGbCtD
Hydrocortisone—ABCG2—Vemurafenib—skin cancer	0.0461	0.133	CbGbCtD
Hydrocortisone—CYP2C8—Vismodegib—skin cancer	0.0311	0.0898	CbGbCtD
Hydrocortisone—ABCG2—Dactinomycin—skin cancer	0.0306	0.0885	CbGbCtD
Hydrocortisone—ABCB1—Vismodegib—skin cancer	0.021	0.0608	CbGbCtD
Hydrocortisone—ABCG2—Fluorouracil—skin cancer	0.0207	0.0599	CbGbCtD
Hydrocortisone—CYP3A4—Temozolomide—skin cancer	0.0182	0.0525	CbGbCtD
Hydrocortisone—CYP3A4—Imiquimod—skin cancer	0.0182	0.0525	CbGbCtD
Hydrocortisone—ABCG2—Docetaxel—skin cancer	0.0158	0.0457	CbGbCtD
Hydrocortisone—CYP3A4—Vismodegib—skin cancer	0.0126	0.0364	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0117	0.0338	CbGbCtD
Hydrocortisone—CYP3A7—Docetaxel—skin cancer	0.0117	0.0338	CbGbCtD
Hydrocortisone—ABCB1—Dactinomycin—skin cancer	0.011	0.0319	CbGbCtD
Hydrocortisone—CYP2C8—Fluorouracil—skin cancer	0.011	0.0319	CbGbCtD
Hydrocortisone—CYP3A4—Vemurafenib—skin cancer	0.00996	0.0288	CbGbCtD
Hydrocortisone—CYP3A5—Docetaxel—skin cancer	0.00876	0.0253	CbGbCtD
Hydrocortisone—ABCB1—Docetaxel—skin cancer	0.0057	0.0165	CbGbCtD
Hydrocortisone—CYP3A4—Docetaxel—skin cancer	0.00342	0.00988	CbGbCtD
Hydrocortisone—SHBG—hindlimb—skin cancer	0.00204	0.108	CbGeAlD
Hydrocortisone—ANXA1—nerve—skin cancer	0.00185	0.0984	CbGeAlD
Hydrocortisone—ANXA1—hair follicle—skin cancer	0.00155	0.0824	CbGeAlD
Hydrocortisone—ANXA1—nipple—skin cancer	0.00105	0.0558	CbGeAlD
Hydrocortisone—ANXA1—neck—skin cancer	0.00104	0.0553	CbGeAlD
Hydrocortisone—ANXA1—connective tissue—skin cancer	0.000746	0.0396	CbGeAlD
Hydrocortisone—ANXA1—epithelium—skin cancer	0.000708	0.0376	CbGeAlD
Hydrocortisone—SHBG—neck—skin cancer	0.000695	0.0369	CbGeAlD
Hydrocortisone—ANXA1—skin of body—skin cancer	0.000673	0.0358	CbGeAlD
Hydrocortisone—NR3C1—nerve—skin cancer	0.000643	0.0342	CbGeAlD
Hydrocortisone—ANXA1—mammalian vulva—skin cancer	0.000614	0.0326	CbGeAlD
Hydrocortisone—ANXA1—lymphoid tissue—skin cancer	0.000545	0.029	CbGeAlD
Hydrocortisone—ANXA1—female reproductive system—skin cancer	0.000526	0.0279	CbGeAlD
Hydrocortisone—SHBG—connective tissue—skin cancer	0.000498	0.0265	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—skin cancer	0.000451	0.024	CbGeAlD
Hydrocortisone—ANXA1—head—skin cancer	0.000439	0.0233	CbGeAlD
Hydrocortisone—NR3C1—nipple—skin cancer	0.000365	0.0194	CbGeAlD
Hydrocortisone—NR3C1—neck—skin cancer	0.000361	0.0192	CbGeAlD
Hydrocortisone—SHBG—female reproductive system—skin cancer	0.000351	0.0187	CbGeAlD
Hydrocortisone—ANXA1—lymph node—skin cancer	0.000308	0.0163	CbGeAlD
Hydrocortisone—ABCB1—blood vessel—skin cancer	0.00027	0.0144	CbGeAlD
Hydrocortisone—NR3C1—connective tissue—skin cancer	0.000259	0.0138	CbGeAlD
Hydrocortisone—NR3C1—epithelium—skin cancer	0.000246	0.0131	CbGeAlD
Hydrocortisone—SLCO1A2—head—skin cancer	0.000244	0.013	CbGeAlD
Hydrocortisone—NR3C1—skin of body—skin cancer	0.000234	0.0124	CbGeAlD
Hydrocortisone—ABCG2—mammalian vulva—skin cancer	0.000232	0.0123	CbGeAlD
Hydrocortisone—ANXA1—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000222	0.0673	CbGpPWpGaD
Hydrocortisone—NR3C1—mammalian vulva—skin cancer	0.000213	0.0113	CbGeAlD
Hydrocortisone—CYP2C8—female reproductive system—skin cancer	0.000204	0.0108	CbGeAlD
Hydrocortisone—NR3C1—lymphoid tissue—skin cancer	0.000189	0.0101	CbGeAlD
Hydrocortisone—Oesophagitis—Docetaxel—skin cancer	0.000185	0.00196	CcSEcCtD
Hydrocortisone—Decreased appetite—Vemurafenib—skin cancer	0.000185	0.00196	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000184	0.00194	CcSEcCtD
Hydrocortisone—Fatigue—Vemurafenib—skin cancer	0.000183	0.00194	CcSEcCtD
Hydrocortisone—NR3C1—female reproductive system—skin cancer	0.000183	0.0097	CbGeAlD
Hydrocortisone—Haemoglobin—Bleomycin—skin cancer	0.000182	0.00193	CcSEcCtD
Hydrocortisone—Oedema—Imiquimod—skin cancer	0.000181	0.00192	CcSEcCtD
Hydrocortisone—Haemorrhage—Bleomycin—skin cancer	0.000181	0.00192	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Docetaxel—skin cancer	0.00018	0.00191	CcSEcCtD
Hydrocortisone—Infection—Imiquimod—skin cancer	0.00018	0.00191	CcSEcCtD
Hydrocortisone—Muscular weakness—Fluorouracil—skin cancer	0.00018	0.0019	CcSEcCtD
Hydrocortisone—Shock—Imiquimod—skin cancer	0.000179	0.00189	CcSEcCtD
Hydrocortisone—Nervous system disorder—Imiquimod—skin cancer	0.000178	0.00188	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Temozolomide—skin cancer	0.000178	0.00188	CcSEcCtD
Hydrocortisone—Tachycardia—Imiquimod—skin cancer	0.000177	0.00187	CcSEcCtD
Hydrocortisone—Skin disorder—Imiquimod—skin cancer	0.000176	0.00186	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Imiquimod—skin cancer	0.000175	0.00186	CcSEcCtD
Hydrocortisone—Weight increased—Temozolomide—skin cancer	0.000174	0.00184	CcSEcCtD
Hydrocortisone—Weight decreased—Temozolomide—skin cancer	0.000173	0.00183	CcSEcCtD
Hydrocortisone—Anorexia—Imiquimod—skin cancer	0.000173	0.00183	CcSEcCtD
Hydrocortisone—Infestation NOS—Temozolomide—skin cancer	0.000171	0.0018	CcSEcCtD
Hydrocortisone—Infestation—Temozolomide—skin cancer	0.000171	0.0018	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Docetaxel—skin cancer	0.00017	0.0018	CcSEcCtD
Hydrocortisone—Body temperature increased—Vemurafenib—skin cancer	0.000168	0.00178	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Temozolomide—skin cancer	0.000167	0.00177	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000165	0.00175	CcSEcCtD
Hydrocortisone—Insomnia—Imiquimod—skin cancer	0.000164	0.00174	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000164	0.00173	CcSEcCtD
Hydrocortisone—Paraesthesia—Imiquimod—skin cancer	0.000163	0.00172	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Docetaxel—skin cancer	0.000162	0.00172	CcSEcCtD
Hydrocortisone—Dyspepsia—Imiquimod—skin cancer	0.00016	0.00169	CcSEcCtD
Hydrocortisone—Erythema—Bleomycin—skin cancer	0.000158	0.00167	CcSEcCtD
Hydrocortisone—Decreased appetite—Imiquimod—skin cancer	0.000158	0.00167	CcSEcCtD
Hydrocortisone—Infestation NOS—Fluorouracil—skin cancer	0.000157	0.00166	CcSEcCtD
Hydrocortisone—Infestation—Fluorouracil—skin cancer	0.000157	0.00166	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vemurafenib—skin cancer	0.000157	0.00166	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Imiquimod—skin cancer	0.000157	0.00166	CcSEcCtD
Hydrocortisone—Fatigue—Imiquimod—skin cancer	0.000156	0.00166	CcSEcCtD
Hydrocortisone—Pain—Imiquimod—skin cancer	0.000155	0.00164	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Fluorouracil—skin cancer	0.000155	0.00164	CcSEcCtD
Hydrocortisone—Myocardial infarction—Fluorouracil—skin cancer	0.000154	0.00163	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Fluorouracil—skin cancer	0.000154	0.00163	CcSEcCtD
Hydrocortisone—Haemoglobin—Temozolomide—skin cancer	0.000154	0.00163	CcSEcCtD
Hydrocortisone—Haemorrhage—Temozolomide—skin cancer	0.000153	0.00162	CcSEcCtD
Hydrocortisone—Asthenia—Vemurafenib—skin cancer	0.000153	0.00162	CcSEcCtD
Hydrocortisone—NR3C1—head—skin cancer	0.000153	0.00811	CbGeAlD
Hydrocortisone—Hallucination—Temozolomide—skin cancer	0.000152	0.00161	CcSEcCtD
Hydrocortisone—Cardiac failure—Docetaxel—skin cancer	0.000151	0.0016	CcSEcCtD
Hydrocortisone—Pruritus—Vemurafenib—skin cancer	0.000151	0.00159	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Temozolomide—skin cancer	0.00015	0.00159	CcSEcCtD
Hydrocortisone—Lethargy—Docetaxel—skin cancer	0.00015	0.00159	CcSEcCtD
Hydrocortisone—Feeling abnormal—Imiquimod—skin cancer	0.00015	0.00158	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Imiquimod—skin cancer	0.000148	0.00157	CcSEcCtD
Hydrocortisone—Erythema—Dactinomycin—skin cancer	0.000147	0.00156	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Bleomycin—skin cancer	0.000147	0.00155	CcSEcCtD
Hydrocortisone—Diarrhoea—Vemurafenib—skin cancer	0.000146	0.00154	CcSEcCtD
Hydrocortisone—Urticaria—Imiquimod—skin cancer	0.000144	0.00153	CcSEcCtD
Hydrocortisone—Body temperature increased—Imiquimod—skin cancer	0.000143	0.00152	CcSEcCtD
Hydrocortisone—Abdominal pain—Imiquimod—skin cancer	0.000143	0.00152	CcSEcCtD
Hydrocortisone—Eye disorder—Temozolomide—skin cancer	0.000143	0.00151	CcSEcCtD
Hydrocortisone—Malaise—Bleomycin—skin cancer	0.000142	0.00151	CcSEcCtD
Hydrocortisone—Haemoglobin—Fluorouracil—skin cancer	0.000142	0.0015	CcSEcCtD
Hydrocortisone—Haemorrhage—Fluorouracil—skin cancer	0.000141	0.00149	CcSEcCtD
Hydrocortisone—Dizziness—Vemurafenib—skin cancer	0.000141	0.00149	CcSEcCtD
Hydrocortisone—Immune system disorder—Temozolomide—skin cancer	0.000138	0.00146	CcSEcCtD
Hydrocortisone—CYP3A4—female reproductive system—skin cancer	0.000138	0.00734	CbGeAlD
Hydrocortisone—Ill-defined disorder—Dactinomycin—skin cancer	0.000137	0.00145	CcSEcCtD
Hydrocortisone—Vomiting—Vemurafenib—skin cancer	0.000135	0.00143	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—KRT17—skin cancer	0.000135	0.041	CbGpPWpGaD
Hydrocortisone—Dry skin—Docetaxel—skin cancer	0.000135	0.00143	CcSEcCtD
Hydrocortisone—Myalgia—Bleomycin—skin cancer	0.000134	0.00142	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Docetaxel—skin cancer	0.000134	0.00142	CcSEcCtD
Hydrocortisone—Rash—Vemurafenib—skin cancer	0.000134	0.00142	CcSEcCtD
Hydrocortisone—Mental disorder—Temozolomide—skin cancer	0.000134	0.00142	CcSEcCtD
Hydrocortisone—Dermatitis—Vemurafenib—skin cancer	0.000134	0.00142	CcSEcCtD
Hydrocortisone—Hypersensitivity—Imiquimod—skin cancer	0.000134	0.00141	CcSEcCtD
Hydrocortisone—Headache—Vemurafenib—skin cancer	0.000133	0.00141	CcSEcCtD
Hydrocortisone—Malnutrition—Temozolomide—skin cancer	0.000133	0.00141	CcSEcCtD
Hydrocortisone—Erythema—Temozolomide—skin cancer	0.000133	0.00141	CcSEcCtD
Hydrocortisone—Discomfort—Bleomycin—skin cancer	0.000133	0.00141	CcSEcCtD
Hydrocortisone—Malaise—Dactinomycin—skin cancer	0.000133	0.00141	CcSEcCtD
Hydrocortisone—ABCB1—epithelium—skin cancer	0.000132	0.00699	CbGeAlD
Hydrocortisone—Asthenia—Imiquimod—skin cancer	0.00013	0.00138	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00013	0.00137	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Bleomycin—skin cancer	0.000129	0.00136	CcSEcCtD
Hydrocortisone—Oedema—Bleomycin—skin cancer	0.000129	0.00136	CcSEcCtD
Hydrocortisone—Pruritus—Imiquimod—skin cancer	0.000128	0.00136	CcSEcCtD
Hydrocortisone—Infection—Bleomycin—skin cancer	0.000128	0.00135	CcSEcCtD
Hydrocortisone—Nausea—Vemurafenib—skin cancer	0.000126	0.00134	CcSEcCtD
Hydrocortisone—Arrhythmia—Fluorouracil—skin cancer	0.000126	0.00133	CcSEcCtD
Hydrocortisone—Myalgia—Dactinomycin—skin cancer	0.000125	0.00133	CcSEcCtD
Hydrocortisone—Diarrhoea—Imiquimod—skin cancer	0.000124	0.00131	CcSEcCtD
Hydrocortisone—Discomfort—Dactinomycin—skin cancer	0.000124	0.00131	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Temozolomide—skin cancer	0.000124	0.00131	CcSEcCtD
Hydrocortisone—Anorexia—Bleomycin—skin cancer	0.000123	0.0013	CcSEcCtD
Hydrocortisone—Erythema—Fluorouracil—skin cancer	0.000123	0.0013	CcSEcCtD
Hydrocortisone—Angioedema—Temozolomide—skin cancer	0.000122	0.00129	CcSEcCtD
Hydrocortisone—Hypotension—Bleomycin—skin cancer	0.00012	0.00127	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—KRT14—skin cancer	0.00012	0.0365	CbGpPWpGaD
Hydrocortisone—Oedema—Dactinomycin—skin cancer	0.00012	0.00127	CcSEcCtD
Hydrocortisone—Malaise—Temozolomide—skin cancer	0.00012	0.00127	CcSEcCtD
Hydrocortisone—Dizziness—Imiquimod—skin cancer	0.00012	0.00127	CcSEcCtD
Hydrocortisone—Vertigo—Temozolomide—skin cancer	0.00012	0.00127	CcSEcCtD
Hydrocortisone—Infection—Dactinomycin—skin cancer	0.000119	0.00126	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—CSPG4—skin cancer	0.000118	0.0358	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000117	0.00124	CcSEcCtD
Hydrocortisone—ABCG2—lymph node—skin cancer	0.000116	0.00616	CbGeAlD
Hydrocortisone—Paraesthesia—Bleomycin—skin cancer	0.000116	0.00122	CcSEcCtD
Hydrocortisone—Weight increased—Docetaxel—skin cancer	0.000116	0.00122	CcSEcCtD
Hydrocortisone—Convulsion—Temozolomide—skin cancer	0.000115	0.00122	CcSEcCtD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000115	0.035	CbGpPWpGaD
Hydrocortisone—Vomiting—Imiquimod—skin cancer	0.000115	0.00122	CcSEcCtD
Hydrocortisone—Weight decreased—Docetaxel—skin cancer	0.000115	0.00122	CcSEcCtD
Hydrocortisone—Hypertension—Temozolomide—skin cancer	0.000115	0.00122	CcSEcCtD
Hydrocortisone—Anorexia—Dactinomycin—skin cancer	0.000115	0.00121	CcSEcCtD
Hydrocortisone—Rash—Imiquimod—skin cancer	0.000114	0.00121	CcSEcCtD
Hydrocortisone—Dermatitis—Imiquimod—skin cancer	0.000114	0.00121	CcSEcCtD
Hydrocortisone—ABCB1—mammalian vulva—skin cancer	0.000114	0.00607	CbGeAlD
Hydrocortisone—Headache—Imiquimod—skin cancer	0.000114	0.0012	CcSEcCtD
Hydrocortisone—Myalgia—Temozolomide—skin cancer	0.000113	0.0012	CcSEcCtD
Hydrocortisone—Infestation NOS—Docetaxel—skin cancer	0.000113	0.0012	CcSEcCtD
Hydrocortisone—Infestation—Docetaxel—skin cancer	0.000113	0.0012	CcSEcCtD
Hydrocortisone—Anxiety—Temozolomide—skin cancer	0.000113	0.0012	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000113	0.00119	CcSEcCtD
Hydrocortisone—Discomfort—Temozolomide—skin cancer	0.000112	0.00119	CcSEcCtD
Hydrocortisone—Decreased appetite—Bleomycin—skin cancer	0.000112	0.00119	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Docetaxel—skin cancer	0.000112	0.00118	CcSEcCtD
Hydrocortisone—Myocardial infarction—Docetaxel—skin cancer	0.000111	0.00118	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Docetaxel—skin cancer	0.000111	0.00118	CcSEcCtD
Hydrocortisone—Pain—Bleomycin—skin cancer	0.00011	0.00117	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00011	0.00116	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.000109	0.033	CbGpPWpGaD
Hydrocortisone—Anaphylactic shock—Temozolomide—skin cancer	0.000109	0.00115	CcSEcCtD
Hydrocortisone—Oedema—Temozolomide—skin cancer	0.000109	0.00115	CcSEcCtD
Hydrocortisone—Infection—Temozolomide—skin cancer	0.000108	0.00114	CcSEcCtD
Hydrocortisone—Nausea—Imiquimod—skin cancer	0.000108	0.00114	CcSEcCtD
Hydrocortisone—NR3C1—lymph node—skin cancer	0.000107	0.00568	CbGeAlD
Hydrocortisone—Nervous system disorder—Temozolomide—skin cancer	0.000107	0.00113	CcSEcCtD
Hydrocortisone—Convulsion—Fluorouracil—skin cancer	0.000106	0.00113	CcSEcCtD
Hydrocortisone—Feeling abnormal—Bleomycin—skin cancer	0.000106	0.00112	CcSEcCtD
Hydrocortisone—Skin disorder—Temozolomide—skin cancer	0.000106	0.00112	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Temozolomide—skin cancer	0.000105	0.00111	CcSEcCtD
Hydrocortisone—Myalgia—Fluorouracil—skin cancer	0.000105	0.00111	CcSEcCtD
Hydrocortisone—Decreased appetite—Dactinomycin—skin cancer	0.000105	0.00111	CcSEcCtD
Hydrocortisone—Fatigue—Dactinomycin—skin cancer	0.000104	0.0011	CcSEcCtD
Hydrocortisone—Anorexia—Temozolomide—skin cancer	0.000104	0.0011	CcSEcCtD
Hydrocortisone—Discomfort—Fluorouracil—skin cancer	0.000103	0.00109	CcSEcCtD
Hydrocortisone—Pain—Dactinomycin—skin cancer	0.000103	0.00109	CcSEcCtD
Hydrocortisone—Urticaria—Bleomycin—skin cancer	0.000102	0.00108	CcSEcCtD
Hydrocortisone—Haemoglobin—Docetaxel—skin cancer	0.000102	0.00108	CcSEcCtD
Hydrocortisone—Body temperature increased—Bleomycin—skin cancer	0.000102	0.00108	CcSEcCtD
Hydrocortisone—Haemorrhage—Docetaxel—skin cancer	0.000102	0.00108	CcSEcCtD
Hydrocortisone—ABCB1—lymphoid tissue—skin cancer	0.000101	0.00539	CbGeAlD
Hydrocortisone—Oedema—Fluorouracil—skin cancer	0.0001	0.00106	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Fluorouracil—skin cancer	0.0001	0.00106	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Docetaxel—skin cancer	0.0001	0.00106	CcSEcCtD
Hydrocortisone—Infection—Fluorouracil—skin cancer	9.95e-05	0.00105	CcSEcCtD
Hydrocortisone—Feeling abnormal—Dactinomycin—skin cancer	9.91e-05	0.00105	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Temozolomide—skin cancer	9.91e-05	0.00105	CcSEcCtD
Hydrocortisone—Insomnia—Temozolomide—skin cancer	9.84e-05	0.00104	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Dactinomycin—skin cancer	9.83e-05	0.00104	CcSEcCtD
Hydrocortisone—Nervous system disorder—Fluorouracil—skin cancer	9.83e-05	0.00104	CcSEcCtD
Hydrocortisone—Tachycardia—Fluorouracil—skin cancer	9.78e-05	0.00103	CcSEcCtD
Hydrocortisone—ABCB1—female reproductive system—skin cancer	9.78e-05	0.00519	CbGeAlD
Hydrocortisone—Paraesthesia—Temozolomide—skin cancer	9.77e-05	0.00103	CcSEcCtD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	9.67e-05	0.0293	CbGpPWpGaD
Hydrocortisone—Dyspepsia—Temozolomide—skin cancer	9.57e-05	0.00101	CcSEcCtD
Hydrocortisone—Anorexia—Fluorouracil—skin cancer	9.55e-05	0.00101	CcSEcCtD
Hydrocortisone—Eye disorder—Docetaxel—skin cancer	9.51e-05	0.00101	CcSEcCtD
Hydrocortisone—Abdominal pain—Dactinomycin—skin cancer	9.51e-05	0.00101	CcSEcCtD
Hydrocortisone—Body temperature increased—Dactinomycin—skin cancer	9.51e-05	0.00101	CcSEcCtD
Hydrocortisone—Hypersensitivity—Bleomycin—skin cancer	9.5e-05	0.001	CcSEcCtD
Hydrocortisone—Decreased appetite—Temozolomide—skin cancer	9.45e-05	0.001	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Temozolomide—skin cancer	9.39e-05	0.000993	CcSEcCtD
Hydrocortisone—Fatigue—Temozolomide—skin cancer	9.38e-05	0.000992	CcSEcCtD
Hydrocortisone—Hypotension—Fluorouracil—skin cancer	9.36e-05	0.00099	CcSEcCtD
Hydrocortisone—Pain—Temozolomide—skin cancer	9.3e-05	0.000984	CcSEcCtD
Hydrocortisone—Asthenia—Bleomycin—skin cancer	9.25e-05	0.000979	CcSEcCtD
Hydrocortisone—Immune system disorder—Docetaxel—skin cancer	9.19e-05	0.000973	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Fluorouracil—skin cancer	9.13e-05	0.000966	CcSEcCtD
Hydrocortisone—Pruritus—Bleomycin—skin cancer	9.12e-05	0.000965	CcSEcCtD
Hydrocortisone—Arrhythmia—Docetaxel—skin cancer	9.09e-05	0.000962	CcSEcCtD
Hydrocortisone—Insomnia—Fluorouracil—skin cancer	9.06e-05	0.000959	CcSEcCtD
Hydrocortisone—Paraesthesia—Fluorouracil—skin cancer	9e-05	0.000952	CcSEcCtD
Hydrocortisone—Feeling abnormal—Temozolomide—skin cancer	8.96e-05	0.000948	CcSEcCtD
Hydrocortisone—Mental disorder—Docetaxel—skin cancer	8.92e-05	0.000943	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Temozolomide—skin cancer	8.89e-05	0.000941	CcSEcCtD
Hydrocortisone—Malnutrition—Docetaxel—skin cancer	8.86e-05	0.000937	CcSEcCtD
Hydrocortisone—Erythema—Docetaxel—skin cancer	8.86e-05	0.000937	CcSEcCtD
Hydrocortisone—Hypersensitivity—Dactinomycin—skin cancer	8.86e-05	0.000937	CcSEcCtD
Hydrocortisone—Dyspepsia—Fluorouracil—skin cancer	8.82e-05	0.000933	CcSEcCtD
Hydrocortisone—Decreased appetite—Fluorouracil—skin cancer	8.71e-05	0.000921	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Fluorouracil—skin cancer	8.65e-05	0.000915	CcSEcCtD
Hydrocortisone—Urticaria—Temozolomide—skin cancer	8.64e-05	0.000914	CcSEcCtD
Hydrocortisone—Asthenia—Dactinomycin—skin cancer	8.63e-05	0.000913	CcSEcCtD
Hydrocortisone—Abdominal pain—Temozolomide—skin cancer	8.6e-05	0.000909	CcSEcCtD
Hydrocortisone—Body temperature increased—Temozolomide—skin cancer	8.6e-05	0.000909	CcSEcCtD
Hydrocortisone—Pain—Fluorouracil—skin cancer	8.57e-05	0.000906	CcSEcCtD
Hydrocortisone—ANXA1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	8.37e-05	0.0254	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Fluorouracil—skin cancer	8.26e-05	0.000874	CcSEcCtD
Hydrocortisone—Diarrhoea—Dactinomycin—skin cancer	8.23e-05	0.00087	CcSEcCtD
Hydrocortisone—Vomiting—Bleomycin—skin cancer	8.2e-05	0.000867	CcSEcCtD
Hydrocortisone—ABCB1—head—skin cancer	8.17e-05	0.00434	CbGeAlD
Hydrocortisone—Rash—Bleomycin—skin cancer	8.13e-05	0.00086	CcSEcCtD
Hydrocortisone—Dermatitis—Bleomycin—skin cancer	8.12e-05	0.000859	CcSEcCtD
Hydrocortisone—Hypersensitivity—Temozolomide—skin cancer	8.01e-05	0.000848	CcSEcCtD
Hydrocortisone—Urticaria—Fluorouracil—skin cancer	7.96e-05	0.000842	CcSEcCtD
Hydrocortisone—Syncope—Docetaxel—skin cancer	7.95e-05	0.000841	CcSEcCtD
Hydrocortisone—Body temperature increased—Fluorouracil—skin cancer	7.92e-05	0.000838	CcSEcCtD
Hydrocortisone—Asthenia—Temozolomide—skin cancer	7.8e-05	0.000825	CcSEcCtD
Hydrocortisone—Loss of consciousness—Docetaxel—skin cancer	7.79e-05	0.000824	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—MC1R—skin cancer	7.7e-05	0.0234	CbGpPWpGaD
Hydrocortisone—Pruritus—Temozolomide—skin cancer	7.69e-05	0.000814	CcSEcCtD
Hydrocortisone—Convulsion—Docetaxel—skin cancer	7.68e-05	0.000812	CcSEcCtD
Hydrocortisone—Nausea—Bleomycin—skin cancer	7.66e-05	0.00081	CcSEcCtD
Hydrocortisone—Hypertension—Docetaxel—skin cancer	7.65e-05	0.000809	CcSEcCtD
Hydrocortisone—Vomiting—Dactinomycin—skin cancer	7.65e-05	0.000809	CcSEcCtD
Hydrocortisone—Rash—Dactinomycin—skin cancer	7.58e-05	0.000802	CcSEcCtD
Hydrocortisone—Myalgia—Docetaxel—skin cancer	7.54e-05	0.000798	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	7.49e-05	0.000793	CcSEcCtD
Hydrocortisone—Diarrhoea—Temozolomide—skin cancer	7.44e-05	0.000787	CcSEcCtD
Hydrocortisone—Hypersensitivity—Fluorouracil—skin cancer	7.38e-05	0.000781	CcSEcCtD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	7.33e-05	0.0222	CbGpPWpGaD
Hydrocortisone—Oedema—Docetaxel—skin cancer	7.23e-05	0.000765	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Docetaxel—skin cancer	7.23e-05	0.000765	CcSEcCtD
Hydrocortisone—Dizziness—Temozolomide—skin cancer	7.19e-05	0.000761	CcSEcCtD
Hydrocortisone—Infection—Docetaxel—skin cancer	7.19e-05	0.00076	CcSEcCtD
Hydrocortisone—Nausea—Dactinomycin—skin cancer	7.14e-05	0.000756	CcSEcCtD
Hydrocortisone—Shock—Docetaxel—skin cancer	7.12e-05	0.000753	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—skin cancer	7.09e-05	0.0215	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Docetaxel—skin cancer	7.09e-05	0.00075	CcSEcCtD
Hydrocortisone—Pruritus—Fluorouracil—skin cancer	7.09e-05	0.00075	CcSEcCtD
Hydrocortisone—NR3C1—Adipogenesis—ASIP—skin cancer	7.08e-05	0.0215	CbGpPWpGaD
Hydrocortisone—Tachycardia—Docetaxel—skin cancer	7.06e-05	0.000747	CcSEcCtD
Hydrocortisone—Skin disorder—Docetaxel—skin cancer	7.02e-05	0.000743	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—MSH2—skin cancer	7.02e-05	0.0213	CbGpPWpGaD
Hydrocortisone—Vomiting—Temozolomide—skin cancer	6.91e-05	0.000731	CcSEcCtD
Hydrocortisone—Anorexia—Docetaxel—skin cancer	6.89e-05	0.000729	CcSEcCtD
Hydrocortisone—Rash—Temozolomide—skin cancer	6.86e-05	0.000725	CcSEcCtD
Hydrocortisone—Diarrhoea—Fluorouracil—skin cancer	6.86e-05	0.000725	CcSEcCtD
Hydrocortisone—Dermatitis—Temozolomide—skin cancer	6.85e-05	0.000725	CcSEcCtD
Hydrocortisone—NR3C1—Endoderm Differentiation—NKX2-1—skin cancer	6.83e-05	0.0207	CbGpPWpGaD
Hydrocortisone—Headache—Temozolomide—skin cancer	6.81e-05	0.000721	CcSEcCtD
Hydrocortisone—Hypotension—Docetaxel—skin cancer	6.76e-05	0.000715	CcSEcCtD
Hydrocortisone—Dizziness—Fluorouracil—skin cancer	6.63e-05	0.000701	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—skin cancer	6.6e-05	0.02	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Docetaxel—skin cancer	6.59e-05	0.000697	CcSEcCtD
Hydrocortisone—Insomnia—Docetaxel—skin cancer	6.54e-05	0.000692	CcSEcCtD
Hydrocortisone—Paraesthesia—Docetaxel—skin cancer	6.49e-05	0.000687	CcSEcCtD
Hydrocortisone—Nausea—Temozolomide—skin cancer	6.46e-05	0.000683	CcSEcCtD
Hydrocortisone—Vomiting—Fluorouracil—skin cancer	6.37e-05	0.000674	CcSEcCtD
Hydrocortisone—Dyspepsia—Docetaxel—skin cancer	6.37e-05	0.000673	CcSEcCtD
Hydrocortisone—Rash—Fluorouracil—skin cancer	6.32e-05	0.000668	CcSEcCtD
Hydrocortisone—Dermatitis—Fluorouracil—skin cancer	6.31e-05	0.000668	CcSEcCtD
Hydrocortisone—Decreased appetite—Docetaxel—skin cancer	6.29e-05	0.000665	CcSEcCtD
Hydrocortisone—Headache—Fluorouracil—skin cancer	6.28e-05	0.000664	CcSEcCtD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—HRAS—skin cancer	6.24e-05	0.0189	CbGpPWpGaD
Hydrocortisone—Gastrointestinal disorder—Docetaxel—skin cancer	6.24e-05	0.000661	CcSEcCtD
Hydrocortisone—Fatigue—Docetaxel—skin cancer	6.24e-05	0.00066	CcSEcCtD
Hydrocortisone—Pain—Docetaxel—skin cancer	6.18e-05	0.000654	CcSEcCtD
Hydrocortisone—Feeling abnormal—Docetaxel—skin cancer	5.96e-05	0.00063	CcSEcCtD
Hydrocortisone—Nausea—Fluorouracil—skin cancer	5.95e-05	0.00063	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Docetaxel—skin cancer	5.91e-05	0.000626	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—skin cancer	5.72e-05	0.00304	CbGeAlD
Hydrocortisone—Abdominal pain—Docetaxel—skin cancer	5.72e-05	0.000605	CcSEcCtD
Hydrocortisone—Body temperature increased—Docetaxel—skin cancer	5.72e-05	0.000605	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	5.47e-05	0.0166	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—PTCH2—skin cancer	5.44e-05	0.0165	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Docetaxel—skin cancer	5.33e-05	0.000564	CcSEcCtD
Hydrocortisone—Asthenia—Docetaxel—skin cancer	5.19e-05	0.000549	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	5.18e-05	0.0157	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	5.17e-05	0.0157	CbGpPWpGaD
Hydrocortisone—Pruritus—Docetaxel—skin cancer	5.12e-05	0.000541	CcSEcCtD
Hydrocortisone—Diarrhoea—Docetaxel—skin cancer	4.95e-05	0.000523	CcSEcCtD
Hydrocortisone—Dizziness—Docetaxel—skin cancer	4.78e-05	0.000506	CcSEcCtD
Hydrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—skin cancer	4.72e-05	0.0143	CbGpPWpGaD
Hydrocortisone—Vomiting—Docetaxel—skin cancer	4.6e-05	0.000486	CcSEcCtD
Hydrocortisone—Rash—Docetaxel—skin cancer	4.56e-05	0.000482	CcSEcCtD
Hydrocortisone—Dermatitis—Docetaxel—skin cancer	4.56e-05	0.000482	CcSEcCtD
Hydrocortisone—Headache—Docetaxel—skin cancer	4.53e-05	0.000479	CcSEcCtD
Hydrocortisone—Nausea—Docetaxel—skin cancer	4.3e-05	0.000454	CcSEcCtD
Hydrocortisone—NR3C1—Adipogenesis—PLIN2—skin cancer	4.29e-05	0.013	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	4.06e-05	0.0123	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	3.96e-05	0.012	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—MC1R—skin cancer	3.93e-05	0.0119	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—CDK4—skin cancer	3.92e-05	0.0119	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	3.4e-05	0.0103	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RHOU—skin cancer	3.38e-05	0.0102	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CDK4—skin cancer	3.21e-05	0.00975	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.06e-05	0.00927	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	2.93e-05	0.00889	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—BRAF—skin cancer	2.84e-05	0.00863	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—SHH—skin cancer	2.8e-05	0.0085	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—PTGS2—skin cancer	2.8e-05	0.00849	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	2.8e-05	0.00848	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PTCH2—skin cancer	2.79e-05	0.00847	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—BRAF—skin cancer	2.67e-05	0.00811	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.66e-05	0.00808	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—PTCH1—skin cancer	2.66e-05	0.00806	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—SMO—skin cancer	2.66e-05	0.00806	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.63e-05	0.00799	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—PTGER4—skin cancer	2.59e-05	0.00785	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—MC1R—skin cancer	2.22e-05	0.00674	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	2.19e-05	0.00663	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—MC1R—skin cancer	2.02e-05	0.00612	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.9e-05	0.00577	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—skin cancer	1.85e-05	0.0056	CbGpPWpGaD
Hydrocortisone—Drospirenone—PTGS2—skin cancer	1.71e-05	0.371	CrCbGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	1.67e-05	0.00507	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—skin cancer	1.67e-05	0.00505	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.65e-05	0.00501	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTCH2—skin cancer	1.65e-05	0.005	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.54e-05	0.00467	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL6—skin cancer	1.52e-05	0.00462	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.49e-05	0.00452	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—PTGER4—skin cancer	1.46e-05	0.00443	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	1.45e-05	0.0044	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—SHH—skin cancer	1.44e-05	0.00436	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—skin cancer	1.44e-05	0.00436	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.37e-05	0.00415	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PTCH1—skin cancer	1.36e-05	0.00414	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—SMO—skin cancer	1.36e-05	0.00414	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PLIN2—skin cancer	1.36e-05	0.00413	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	1.35e-05	0.00409	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PTGER4—skin cancer	1.33e-05	0.00403	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.27e-05	0.00387	CbGpPWpGaD
Hydrocortisone—Triamcinolone—PTGS2—skin cancer	1.26e-05	0.274	CrCbGaD
Hydrocortisone—ANXA1—Signaling Pathways—GLI2—skin cancer	1.25e-05	0.00379	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MC1R—skin cancer	1.19e-05	0.00362	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	1.18e-05	0.00359	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.18e-05	0.00358	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—GLI1—skin cancer	1.18e-05	0.00357	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PLIN2—skin cancer	1.17e-05	0.00356	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	1.16e-05	0.00352	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.13e-05	0.00344	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SUFU—skin cancer	1.11e-05	0.00338	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CSPG4—skin cancer	1.1e-05	0.00333	CbGpPWpGaD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	1.08e-05	0.00329	CbGpPWpGaD
Hydrocortisone—Betamethasone—PTGS2—skin cancer	1.03e-05	0.225	CrCbGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	9.86e-06	0.00299	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CSPG4—skin cancer	9.46e-06	0.00287	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	9.43e-06	0.00286	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	9.28e-06	0.00281	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	8.8e-06	0.00267	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SHH—skin cancer	8.5e-06	0.00258	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RASA1—skin cancer	8.45e-06	0.00256	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.12e-06	0.00246	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTCH1—skin cancer	8.06e-06	0.00244	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SMO—skin cancer	8.06e-06	0.00244	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—skin cancer	7.99e-06	0.00242	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTGER4—skin cancer	7.84e-06	0.00238	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ENO2—skin cancer	7.46e-06	0.00226	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PLIN2—skin cancer	7.36e-06	0.00223	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL6—skin cancer	7.32e-06	0.00222	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—skin cancer	7.04e-06	0.00214	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—FOXO4—skin cancer	6.93e-06	0.0021	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—skin cancer	6.45e-06	0.00196	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ENO2—skin cancer	6.43e-06	0.00195	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	6.38e-06	0.00193	CbGpPWpGaD
Hydrocortisone—Dexamethasone—PTGS2—skin cancer	6.02e-06	0.131	CrCbGaD
Hydrocortisone—SLCO1A2—Metabolism—CSPG4—skin cancer	5.93e-06	0.0018	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.83e-06	0.00177	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PLIN2—skin cancer	5.83e-06	0.00177	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PLIN2—skin cancer	5.77e-06	0.00175	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.03e-06	0.00152	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CSPG4—skin cancer	4.7e-06	0.00142	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CSPG4—skin cancer	4.65e-06	0.00141	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TERT—skin cancer	4.63e-06	0.0014	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.52e-06	0.00137	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—IL6—skin cancer	4.46e-06	0.00135	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ERCC2—skin cancer	4.33e-06	0.00131	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PLIN2—skin cancer	4.17e-06	0.00127	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ENO2—skin cancer	4.03e-06	0.00122	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NRAS—skin cancer	3.9e-06	0.00118	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—skin cancer	3.85e-06	0.00117	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ERCC2—skin cancer	3.73e-06	0.00113	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—BRAF—skin cancer	3.67e-06	0.00111	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PLIN2—skin cancer	3.62e-06	0.0011	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CSPG4—skin cancer	3.36e-06	0.00102	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KRAS—skin cancer	3.36e-06	0.00102	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	3.23e-06	0.00098	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ENO2—skin cancer	3.19e-06	0.000968	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ENO2—skin cancer	3.16e-06	0.00096	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.15e-06	0.000956	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PLIN2—skin cancer	3.15e-06	0.000955	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CSPG4—skin cancer	2.91e-06	0.000884	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—skin cancer	2.85e-06	0.000865	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL6—skin cancer	2.73e-06	0.000828	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—skin cancer	2.6e-06	0.000788	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CSPG4—skin cancer	2.54e-06	0.00077	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ERCC2—skin cancer	2.4e-06	0.000728	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ERCC2—skin cancer	2.34e-06	0.00071	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—skin cancer	2.3e-06	0.000699	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ENO2—skin cancer	2.29e-06	0.000694	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—skin cancer	2.24e-06	0.000679	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.16e-06	0.000656	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—skin cancer	1.98e-06	0.000601	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ENO2—skin cancer	1.98e-06	0.000601	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PLIN2—skin cancer	1.94e-06	0.000589	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.92e-06	0.000583	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ERCC2—skin cancer	1.85e-06	0.000562	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ERCC2—skin cancer	1.84e-06	0.000557	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—skin cancer	1.76e-06	0.000534	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ENO2—skin cancer	1.73e-06	0.000523	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—skin cancer	1.69e-06	0.000511	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL6—skin cancer	1.61e-06	0.000489	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CSPG4—skin cancer	1.56e-06	0.000474	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.55e-06	0.00047	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—skin cancer	1.4e-06	0.000426	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ERCC2—skin cancer	1.33e-06	0.000403	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ERCC2—skin cancer	1.15e-06	0.000349	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—skin cancer	1.11e-06	0.000337	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—skin cancer	1.1e-06	0.000334	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ENO2—skin cancer	1.06e-06	0.000322	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ERCC2—skin cancer	1e-06	0.000304	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—skin cancer	7.97e-07	0.000242	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—skin cancer	6.9e-07	0.000209	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ERCC2—skin cancer	6.18e-07	0.000187	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—skin cancer	6.01e-07	0.000182	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—skin cancer	3.7e-07	0.000112	CbGpPWpGaD
